Canyam
AI summaries for academic research
Home
Preprint
Subscribe
Favorites
Tools
Analysis
Summary
Not logged in
Back
Journal Details
B
biologics: targets and therapy
IF
Papers
24
Citations
Related Insights
0
subscribe
Journal Papers
30
Related Insights
0
Journal Papers
30
Publication Date
Publication Date
IF
Citations
Vunakizumab for IL-17A–Mediated Diseases: A Review in Psoriasis and Spondyloarthritis
biologics: targets and therapy
IF
0
2026-06-08
0
OA
AI
Hongzhuo Yan; Yu Chen; Yali Song; Min Yan; Kexiang Yan
Share
Save
Immunological Biomarkers in Glioblastoma: Targeting T and NK Cells for Enhanced Diagnosis and Prognosis
biologics: targets and therapy
IF
0
2026-05-29
0
OA
AI
Amir Mohammad Akbari; Shahriyar Bourbour; Maryam Sadat Seyedmehdi; Sara Shiari; Auob Rustamzadeh; Farhad Seif; Shirin Farivar
Share
Save
MicroRNA-661 Suppresses Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells and Endothelial Cells by Targeting CCND2
biologics: targets and therapy
IF
0
2026-05-28
0
OA
AI
Liyang Jiang; Aixiang Yang; Jun Liu, Jie Zhou
Share
Save
Vunakizumab and Acitretin for Elderly Refractory Generalized Pustular Psoriasis: A Case Report and Comprehensive Literature Review
biologics: targets and therapy
IF
0
2026-05-22
0
OA
AI
Shilin Deng; Yu Jiang; Wei Li; Zhirong Shu; Tingnan Chen; Jingyao Liang; Xibao Zhang
Share
Save
Rapid Resolution of Psoriasis Following Low-Dose Interleukin-2 Monotherapy: A Case Report
biologics: targets and therapy
IF
0
2026-05-20
0
OA
AI
Doudou Ma; Zhanguo Li
Share
Save
Long-Term TIE2 Inhibition in a TEK-Mutated Venous Malformation: A 3-Year Clinical Experience
biologics: targets and therapy
IF
0
2026-05-19
0
OA
AI
Paloma Triana; Elena Marín; Covadonga Mendieta; Lucía Fernández; Lara Rodriguez-Laguna; Juan Carlos Lopez-Gutierrez
Share
Save
Enhancement of Gastric Mucosal Defense by Phytomedicine in the Context of <em>H. pylori</em>–Associated Ulcer Disease
biologics: targets and therapy
IF
0
2026-04-14
0
OA
AI
Raja Singh Paulraj; Parthasarathi Perumal; Arunkumar Ramachandran; Anbazhagan Sathiyaseelan
Share
Save
Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Risk
biologics: targets and therapy
IF
0
2026-04-13
0
OA
AI
Simeon Ikechukwu Egba; Innocent Ogheneovo Orhonigbe; Ngozi Kalu Achi; Gavin Chibundu Ikechukwu; Charles Nnanna Chukwu; Chukwudi Humphrey Omeoga
Share
Save
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review
biologics: targets and therapy
IF
0
2026-03-31
0
OA
AI
Noon Elimam; Shams Samih Albarari; Yara Shaalan; Shazaa Mahmoud Elsheikh; Ainaa A Alzamari; Nourhan Elmekkawi; Rahaf Mogahed; Razan H Alghuweiri
Share
Save
Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Review
biologics: targets and therapy
IF
0
2026-03-16
0
OA
AI
Olena Garmish; Svitlana Smiyan; Roman Komorovsky; Ivan Bilozetskyi
Share
Save
Late-Onset Ocular Myasthenia Gravis–Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report
biologics: targets and therapy
IF
0
2026-03-04
0
OA
AI
Arwa Qaqish; Arwa Al Anber; Ghada Abdelhafez
Share
Save
First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparison
biologics: targets and therapy
IF
0
2026-02-28
0
OA
AI
Yi Zhu, Xiao Qi, Senmiao Ni, Wenting Qiu, Mengkai Chen
Share
Save
Network Pharmacology-Based Exploration: Non-Targeted Metabolites of <em>Lactobacillus</em>-Fermented <em>Chaenomeles speciosa (Sweet) Nakai; Smilax glabra Roxb</em>. and <em>Pueraria montana var. Lobata</em> in Uric Acid Metabolism Intervention
biologics: targets and therapy
IF
0
2026-02-24
0
OA
AI
Wei Tan, Zongjun Li
Share
Save
Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab
biologics: targets and therapy
IF
0
2026-01-20
0
OA
AI
Haruka Otake, Satohiro Matsumoto, Hirosato Mashima
Share
Save
Research on the Role of Autophagy in Vascular Endothelial Cells in the Healing of Chronic Refractory Wounds
biologics: targets and therapy
IF
0
2026-01-13
0
OA
AI
Lao Riling; Fan Kunyue; Gan Liyan; Wang Yaya; Ni Baoling; Li Jiehui
Share
Save
Teclistamab for Relapsed or Refractory Multiple Myeloma: A Review of Efficacy; Safety; Resistance Mechanisms and Future Directions
biologics: targets and therapy
IF
0
2026-01-13
0
OA
AI
Bénédicte Piron; Philippe Moreau; Cyrille Touzeau
Share
Save
Mesenchymal Stem Cell Therapy in Osteoarthritis and Rheumatoid Arthritis: A Systematic Review of Exosomal microRNAs
Biologics: Targets and Therapy
IF
0
2025-12-30
0
OA
AI
Seyyed Sina Hejazian; Seyyedeh Mina Hejazian; Seyede Saba Mostafavi Montazeri; Sima Abediazar; Sepideh Zununi Vahed; Abolfazl Barzegari
Share
Save
Efficacy; Safety; and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study
Biologics: Targets and Therapy
IF
0
2025-12-18
0
OA
AI
Máté Pápista; Tamás Resál; Péter Bacsur; Diána Kata; Bernadett Farkas; Anita Bálint; Anna Fábián; Renáta Bor; Emese Ivány; Zoltán Szepes; Klaudia Farkas; Zoltán Juhász; Norbert Buzás; Tamás Molnár
Share
Save
Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review
Biologics: Targets and Therapy
IF
0
2025-12-04
0
OA
AI
Giorgio Galoppini, Carlo Garaffoni, Andrea Lotesoriere, Federico Nogarin, Alessandra Bortoluzzi, Marcello Govoni, Ettore Silvagni
Share
Save
Tumor-to-Tumor Metastasis: Breast Cancer Metastasizing to EGFR Exon 19-Mutated Lung Adenocarcinoma with Long-Term Disease-Free Survival
Biologics: Targets and Therapy
IF
0
2025-11-19
0
OA
AI
Yana Zhang; Yang Hao; Han Yang; Xiangli Meng; Shanshan Yang; Jin Wang; Jinling Xie; Ping Lu; Yinghua Ji
Share
Save